Skip Ribbon Commands
Skip to main content
Dr Lawrence Ng Cheng Kiat

Dr Ng Lawrence Cheng Kiat

​MD, MRCP (UK)

Consultant

Singapore General Hospital

Specialty: Haematology

Sub-specialties: Lymphoma, Myeloma

Conditions Treated by this Doctor:
Chronic lymphocytic leukemia, Hodgkin Lymphoma, Multiple Myeloma, Non-Hodgkin's Lymphoma (NHL).

Clinical Appointments

  • Consultant SingHealth Duke-NUS Blood Cancer Centre
  • Consultant Haematology Singapore General HospitalSingapore General Hospital
  • Consultant National Cancer Centre SingaporeNational Cancer Centre Singapore

Academic Appointments

  • Clinical Assistant Professor, College of Clinical Medicine
  • Clinical Tutor, Yong Loo Lin School of Medicine, NUS and Duke-NUS Medical School
  • Clinical Physician Faculty Member (Haematology)

Profile

Dr Lawrence Ng obtained his medical degree in 2010 from Malaysia. He started Internal Medicine residency training followed by obtained MRCP from Royal College of Physician London in 2015. He started Haematology specialty training in 2016 and qualified as haematologist in 2019. He is actively involved in clinical services, clinical trials and education. His areas of interest are lymphoma, haematopoetic stem cell transplantation and cell therapy. Together with Geriatric Medicine colleague, he is working on improving lymphoma care in older adults.

Education

Professional Appointments and Committee Memberships

Awards

  • Singhealth Long Service Awards 10 years - 2022
  • Singhealth Health Quality Service HERO Awards - 2021
  • Service with a Heart 2019, 2021, 2022

Research Interests

Publications

  1. Lawrence, Ng & Christopher, Tham & Francesca, Lim & Yunxin, Chen & Shin, Ong & Chandramouli, Nagarajan & Jing, Lee & Yeow, Goh & Yeh, Linn & Yuh, Lee & Colin, Phipps & Jeffrey, Quek & Than, Hein & Jordan, Hwang & Nicholas, Grigoropoulos & William, Hwang & Aloysius, Ho. (2021). Hematopoetic stem cell transplant in aggressive T and NK/T cell lymphoma - Role of upfront autologous transplant in nodal peripheral T-cell lymphoma. Blood Cell Ther. 2021 Nov 25;4(4):92-100.
  2. Ong, Shin & de Mel, Sanjay & Grigoropoulos, Nicholas & Chen, Yunxin & Tan, Yan & Tan, Melinda & Ng, Lawrence & Lee, Yuh & Phipps, Colin & Goh, Yeow & Yong, Kar & Liu, Xin & Chng, Wee & Lim, Soon & Nagarajan, Chandramouli. (2021). High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma. Blood Cancer Journal. 11. 10.1038/s41408-021-00535-y.
  3. Phipps, Colin & Nagarajan, Chandramouli & Ng, Lawrence & Chua, Jane & Chen, Yunxin & Ong, Shin & Tan, Melinda & Grigoropoulos, Nicholas & Gopalakrishnan, Sathish & Ng, Heng & Hwang, William & Goh, Yeow & Lee, Yuh. (2020). Phase I/II Dose-Escalation Study of Lenalidomide in Combination with R-GDP for Treatment of Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma Followed By Maintenance Lenalidomide. Blood. 136. 25-26. 10.1182/blood-2020-142275.
  4. Jaya-Bodestyne, Sandra & Lee, Lai & Tan, Lay-Kok & Tan, Kok Hian & Østbye, Truls & Malhotra, Rahul & Allen, John & Tan, Sophie & Tan, Melinda & Ng, Lawrence & Yong, Yang & Tan, Thiam Chye. (2020). Risk factors for pregnancy-associated venous thromboembolism in Singapore. Journal of perinatal medicine. -1. 10.1515/jpm-2020-0298.
  5. Chuen Wen, Tan & Wong, Wan & Cheen, Mcvin & Chu, Yvonne & Lim, Shan & Ng, Lawrence & Yeo, Dillon & Morvil, Gayathry & Lee, Lai & Ng, Heng. (2020). Assessment of aPTT-based clot waveform analysis for the detection of haemostatic changes in different types of infections. Scientific Reports. 10. 14186. 10.1038/s41598-020-71063-1.

Research Trials